Guidelines for Quality Control and Preclinical Studies of Stem Cell Preparations (Trial)
Request Guidelines for Quality Control and Preclinical Studies of Stem Cell Preparations (Trial)
  • Local Title:干细胞制剂质量控制及临床前研究指导原则(试行)
  • Country/Region:Chinese Mainland
  • Competent Authority: Former China Food and Drug Administration (CFDA);  Former National Health and Family Planning Commission
  • Type:Guideline
  • Status:In force
  • Release Date:2015-07-31
  • Implementation Date:2015-07-31
Document
Language Source Title Access
ZH Official 干细胞制剂质量控制及临床前研究指导原则(试行) Download
Summary

The Guidelines for Quality Control and Preclinical Studies of Stem Cell Preparations (Trial) was issued on Jul.31, 2015. It aims to strengthen the quality management of stem cell preparations and clinical research in China, which includes:

1. Preface

2. Quality Control of Stem Cell Preparations

3. Preclinical Studies of Stem Cell Preparations